Sign up to our newsletter Subscribe

All Topics
Health Technology Assessment (HTA)
Antimicrobial Resistance (AMR)

Newsletter SignupSubscribe

Search publications, topics, authors and more

News & Insights

News
Events
Insights
Bulletin

News
Events
Insights
Bulletin

Sign up to our newsletter Subscribe

News & Insights

News
Events
Insights
Bulletin

Newsletter SignupSubscribe

News
Events
Insights
Bulletin

Search publications, topics, authors and more

Close

Research & Publications
News & Insights
Education
Innovation Policy Prize

Events
About Us
OHE Experts
Join OHE
Contact Us

Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:

Antimicrobial Resistance (AMR)
Biosimilars
Cell and Gene Therapies
Chronic Diseases
Combination Therapies
COVID-19 Research
Digital Health
Drug Development/R&D
Emerging Markets
EQ-5D and PROMs
Indication-Based Pricing
Health Care Systems
Health Data and Statistics
Health Technology Assessment
Precision Medicine
Prevention
Real-World Evidence
Sustainability
Use of Medicines
Value-Based Pricing
Vaccine Research

Economics of Innovation
Measuring and Valuing Outcomes
Policy, Organisation and Incentives in Health Systems
Value, Affordability and Decision Making

News & Insights

News
Events
Insights
Bulletin

Education

Education Hub
OHE Graduate School
EVIA Programme

Innovation Policy Prize

The Prize Fund
2024 Prize Fund
2022 Prize Fund

Search publications, topics, authors and more

Latest Research & Publications

Value, Affordability, and…
Economic Evaluation

Four Case Studies to Explore the Added Value of Oxford AHSN

Read more

Health Technology Assessment…
Measuring and Valuing Outcomes

“New Age” Decision Making in HTA: Is It Applicable in Asia?

Read more

Health Technology Assessment…
Value, Affordability, and…

How Can Health Technology Assessments in the Asia-Pacific Area Respond to Increased Clinical Uncertainty as a Consequence of Expedited US and EU Regulatory Processes?

Read more

Health Care Systems
Policy, Organisation and…
Quality of Care

Waiting Time Policies in the Health Sector

Read more

Health Technology Assessment…
Value, Affordability, and…

A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications

Read more

Health Technology Assessment…
Value, Affordability, and…

Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making

Read more

Value, Affordability, and…
Health Policy and Regulation

Assessing Trends in SMC Advice Decisions (October 2009- September 2015)

Read more

EQ-5D and PROMs
Measuring and Valuing Outcomes
Clinical Outcomes

New Methods for Modelling EQ-5D-5L Value Sets: An Application to English Data

Read more

00
17
18
19
20
21
22
23
24
25
00

Close

All Publications

Filter by:

Antimicrobial Resistance (AMR)

Biosimilars

Cell and Gene Therapies

Chronic Diseases

Combination Therapies

COVID-19 Research

Digital Health

Drug Development/R&D

Emerging Markets

EQ-5D and PROMs

Indication-Based Pricing

Health Care Systems

Health Data and Statistics

Health Technology Assessment

Precision Medicine

Prevention

Real-World Evidence

Sustainability

Use of Medicines

Value-Based Pricing

Vaccine Research

Economics of Innovation

Measuring and Valuing Outcomes

Policy, Organisation and Incentives in Health Systems

Value, Affordability and Decision Making
News

Events

Insights

Bulletin
Education Hub

OHE Graduate School

EVIA Programme
The Prize Fund

2024 Prize Fund

2022 Prize Fund

Events
About Us
OHE Experts
Join OHE
Contact Us

Newsletter SignupSubscribe

OHE Newsroom

Comment, press releases and other news from OHE.

Graduate school

News
November 2024

Applications open for MSc Fellowship Programme 2025

A switch to vegan diets could save the NHS £6.7 billion per year, new research reveals

News
January 2024

A switch to vegan diets could save the NHS £6.7 billion per year, new research reveals

Filter results by

Topic

Select the product option you would like to filter Topic

Antimicrobial Resistance (AMR) Biosimilars Cell and Gene Therapies Chronic Diseases Combination Therapies COVID-19 Research Dementia Digital Health Drug Development/R&D Emerging Markets EQ-5D and PROMs Health Care Systems Health Data and Statistics Health Technology Assessment (HTA) Indication-Based Pricing Innovation Policy Prize OHE Consulting Precision Medicine Prevention Real World Evidence (RWE) Research Sustainability Use of Medicines Vaccines Value-Based Pricing

Date 1

Select the product option you would like to filter Date

Date From

Month From

Year From

Date To

Month To

Year To

Research-Programme-small

News
February 2017

The Office of Health Economics Becomes a Registered Charity

News
January 2017

Alastair Fischer appointed as Senior Visiting Fellow at OHE

News
January 2017

Value and Cancer: Journal of Cancer Policy Special Issue

News
January 2017

OHE Lunchtime Seminar with Andrea Manca: Economic Evaluation for Decision-making and the Value of Access to Individual Patient Data

News
January 2017

Maynard Matters: A New Publication Covering Alan Maynard’s Contribution to Global Health Economics

News
January 2017

New Publication: Assessing Evidence and Access Associated with NICE HTA Decisions Categorised as “Recommended in Line with Clinical Practice”

News
January 2017

Comparing the Cancer-Specific EORTC-8D and the Generic EQ-5D-3L

News
January 2017

Recently Published: Reports on Policy Options for Formulary Development in Middle-income Countries and A Case Study from Mexico

News
December 2016

New OHE Research Paper: Extrapolation from Progression Free Survival to Overall Survival in Oncology

News
December 2016

OHE at HESG Winter 2017: Meet the Team

News
December 2016

Recently Published: MCDA to Elicit Stakeholders’ Preferences: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma

News
December 2016

New Publication: Important Aspects of Health Not Captured by EQ-5D

00
17
18
19
20
21
22
23
24
25
00

Subscribe To Our Newsletter

Our monthly Bulletin highlights our work alongside the latest from across health economics and health care.

Sign Up Now

Leading intellectual authority on global health economics

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

© 2025 Website Design

An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Share on Mastodon

Enter your Mastodon instance URL (optional)

Powered by GDPR Cookie Compliance

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Enable or Disable Cookies Enabled Disabled

Please enable Strictly Necessary Cookies first so that we can save your preferences!